|
1
|
Wlodzimirow KA, Eslami S, Abu-Hanna A,
Nieuwoudt M and Chamuleau RA: Systematic review: Acute liver
failure-one disease, more than 40 definitions. Aliment Pharmacol
Ther. 35:1245–1256. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Polson J and Lee WM: AASLD position paper:
The management of acute liver failure. Hepatology. 41:1179–1197.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liver, Failure and Artificial Liver Group,
. CSoID and Severe Liver and Disease and Artificial Liver Group,
CSoH: Guideline for diagnosis and treatment of liver failure. Zhong
Hua Lin Chuang Gan Ran Bing Za Zhi. 5:321–327. 2012.(In
Chinese).
|
|
4
|
Ke WM, Li XJ, Yu LN, Lai J, Li XH, Gao ZL
and Chen PJ: Etiological investigation of fatal liver failure
during the course of chronic hepatitis B in southeast China. J
Gastroenterol. 41:347–351. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bernal W, Auzinger G, Dhawan A and Wendon
J: Acute liver failure. Lancet. 376:190–201. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Patton H, Misel M and Gish RG: Acute liver
failure in adults: An evidence-based management protocol for
clinicians. Gastroenterol Hepatol (NY). 8:161–212. 2012.
|
|
7
|
Wu Z, Han M, Chen T, Yan W and Ning Q:
Acute liver failure: Mechanisms of immune-mediated liver injury.
Liver Int. 30:782–794. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Malhi H and Gores GJ: Cellular and
molecular mechanisms of liver injury. Gastroenterology.
134:1641–1654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Weng HL, Cai X, Yuan X, Liebe R, Dooley S,
Li H and Wang TL: Two sides of one coin: massive hepatic necrosis
and progenitor cell-mediated regeneration in acute liver failure.
Front Physiol. 6:1782015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Higuchi N, Kato M, Kotoh K, Kohjima M,
Aishima S, Nakamuta M, Fukui Y, Takayanagi R and Enjoji M:
Methylprednisolone injection via the portal vein suppresses
inflammation in acute liver failure induced in rats by
lipopolysaccharide and d-galactosamine. Liver Int. 27:1342–1348.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lu YS, Pu LY, Li XC and Wang XH:
Methylprednisolone inhibits activated CD4+ T cell survival promoted
by toll-like receptor ligands. Hepatobiliary Pancreat Dis Int.
9:376–383. 2010.PubMed/NCBI
|
|
12
|
Dich J, Vind C and Grunnet N: Long-term
culture of hepatocytes: Effect of hormones on enzyme activities and
metabolic capacity. Hepatology. 8:39–45. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oh HY, Namkoong S, Lee SJ, Por E, Kim CK,
Billiar TR, Han JA, Ha KS, Chung HT, Kwon YG, et al: Dexamethasone
protects primary cultured hepatocytes from death receptor-mediated
apoptosis by upregulation of cFLIP. Cell Death Differ. 13:512–523.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ferrigno A, Gregotti C, Richelmi P and
Vairetti M: Dexamethasone protects cultured rat hepatocytes against
cadmium toxicity: Involvement of cellular thiols. In Vitro Cell Dev
Biol Anim. 46:445–449. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang XQ, Jiang L, You JP, Liu YY, Peng J,
Zhang HY, Xu BY and Mao Q: Efficacy of short-term dexamethasone
therapy in acute-on-chronic pre-liver failure. Hepatol Res.
41:46–53. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mao Q, Zhang HY, You JP and Zhang XQ:
Severe acute exacerbation of chronic hepatitis B during pegylated
interferon treatment and early intervention with corticosteroid.
Virol J. 9:1362012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fujiwara K, Yasui S, Yonemitsu Y, Fukai K,
Arai M, Imazeki F, Suzuki A, Suzuki H, Sadahiro T, Oda S and
Yokosuka O: Efficacy of combination therapy of antiviral and
immunosuppressive drugs for the treatment of severe acute
exacerbation of chronic hepatitis B. J Gastroenterol. 43:711–719.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamada K, Yamamoto Y, Uchiyama A, Ito R,
Aoki Y, Uchida Y, Nagasawa H, Kimura H, Ichiyama T, Fukao T and
Kohno Y: Successful treatment of neonatal herpes simplex-type 1
infection complicated by hemophagocytic lymphohistiocytosis and
acute liver failure. Tohoku J Exp Med. 214:1–5. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Czaja AJ: Corticosteroids or not in severe
acute or fulminant autoimmune hepatitis: Therapeutic brinksmanship
and the point beyond salvation. Liver Transpl. 13:953–955. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Karkhanis J, Verna EC, Chang MS, Stravitz
RT, Schilsky M, Lee WM and Brown RS Jr: Steroid use in acute liver
failure. Hepatology. 59:612–621. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fujiwara K, Yasui S, Yonemitsu Y, Mikata
R, Arai M, Kanda T, Imazeki F, Oda S and Yokosuka O: Efficacy of
high-dose corticosteroid in the early stage of viral acute liver
failure. Hepatol Res. 44:491–501. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Blei AT and Cordoba J: Hepatic
Encephalopathy. Am J Gastroenterol. 96:1968–1976. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang DW, Yin YM and Yao YM: Advances in
the management of acute liver failure. World J Gastroenterol.
19:7069–7077. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lu H, Lu L, Zhang F, Zhai Y and Wang X:
Living donor liver transplantation: where do we stand and where are
we going? Hepatobiliary Surg Nutr. 5:141–144. 2016.PubMed/NCBI
|
|
25
|
Yu S, Jianqin H, Wei W, Jianrong H, Yida
Y, Jifang S, Liang Y, Zhi C and Hongyu J: The efficacy and safety
of nucleos(t)ide analogues in the treatment of HBV-related
acute-on-chronic liver failure: a meta-analysis. Ann Hepatol.
12:364–372. 2013.PubMed/NCBI
|
|
26
|
Kumar M, Satapathy S, Monga R, Das K,
Hissar S, Pande C, Sharma BC and Sarin SK: A randomized controlled
trial of lamivudine to treat acute hepatitis B. Hepatology.
45:97–101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Du WB, Pan XP and Li LJ: Prognostic models
for acute liver failure. Hepatobiliary Pancreat Dis Int. 9:122–128.
2010.PubMed/NCBI
|
|
28
|
Canbay A, Chen SY, Gieseler RK, Malago M,
Karliova M, Gerken G, Broelsch CE and Treichel U: Overweight
patients are more susceptible for acute liver failure.
Hepatogastroenterology. 52:1516–1520. 2005.PubMed/NCBI
|
|
29
|
Rueff B and Benhamou JP: Acute hepatic
necrosis and fulminant hepatic failure. Gut. 14:805–815. 1973.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wong VW and Chan HL: Severe acute
exacerbation of chronic hepatitis B: A unique presentation of a
common disease. J Gastroenterol Hepatol. 24:1179–1186. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lisotti A, Azzaroli F, Buonfiglioli F,
Montagnani M, Alessandrelli F and Mazzella G: Lamivudine treatment
for severe acute HBV hepatitis. Int J Med Sci. 5:309–312. 2008.
View Article : Google Scholar : PubMed/NCBI
|
